Business Context and Reporting Period
Company: Stepan Company
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2010
Business Overview: Stepan produces intermediate chemicals used in consumer and industrial applications. Operations are divided into three segments: Surfactants (78% of sales), Polymers (19%), and Specialty Products (3%). The company operates manufacturing sites in North America, Europe, and Latin America.
Key Financial Metrics
| Metric (in thousands) | Q1 2010 | Q1 2009 |
|---|---|---|
| Net Sales | $337,030 | $318,143 |
| Gross Profit | $63,552 | $48,695 |
| Gross Margin | 18.9% | 15.3% |
| Operating Income | $33,655 | $26,169 |
| Net Income (Attributable to Stepan) | $20,660 | $15,153 |
| Diluted EPS | $1.88 | $1.43 |
| Cash and Equivalents | $75,427 | $6,768 |
| Total Debt | $103,087 | $104,084 |
| Operating Cash Flow | ($3,312) | $15,308 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 6% ($18.9 million) driven by an 8% increase in sales volume and favorable foreign currency translation ($12.5 million). Average selling prices declined, reducing sales growth by $19.3 million due to lower raw material costs passed to customers.
- Profitability: Net income rose 36% to a record $20.7 million. Operating income increased 29% ($7.5 million) due to improved gross margins across all segments and lower raw material costs compared to Q1 2009.
- Segment Performance:
- Surfactants: Sales up 1%; Operating income up 21% ($5.1 million) driven by volume growth and lower costs.
- Polymers: Sales up 30%; Operating income up 156% ($4.0 million) due to a 25% volume increase and higher unit margins as the construction and automotive sectors recovered.
- Specialty Products: Sales up 18%; Operating income up 154% ($2.6 million) due to volume and mix improvements.
- Working Capital: Operating cash flow turned negative ($3.3 million use) compared to a $15.3 million source in Q1 2009. This was primarily due to a $38.4 million increase in accounts receivable and an $11.2 million increase in inventory, driven by higher sales volumes and rising raw material costs.
- Deferred Compensation: The company recorded $1.8 million in deferred compensation income in Q1 2010, compared to $5.5 million in Q1 2009. The lower income was due to a smaller decline in the company's stock price in 2010 compared to the significant drop in 2009.
Outlook, Risks, and Management Commentary
- Outlook: Management expects to sustain earnings momentum driven by sustained margins and improved volumes. The company is investing in capacity expansions in Germany and Brazil. Full-year 2010 capital expenditures are estimated between $65 million and $75 million.
- Liquidity: Cash and cash equivalents totaled $75.4 million. The company has $58.3 million available under its U.S. revolving credit agreement and is negotiating a new $60 million facility. Management anticipates cash from operations and credit facilities will be sufficient to fund commitments.
- Debt: Total debt decreased slightly to $103.1 million. The company is in discussions to borrow $40 million in Q2 2010 for capital expenditures and potential acquisitions. The company remains in compliance with all debt covenants.
- Risks and Contingencies:
- Environmental/Legal: The company faces various environmental liabilities (CERCLA/Superfund). The estimated range of possible losses is $7.3 million to $31.5 million, with an accrued liability of $16.8 million. Specific sites include Maywood (NJ), D'Imperio, Ewan, Lightman Drum, and Wilmington (MA).
- Market Risks: Fluctuations in raw material costs (crude oil derivatives), foreign currency exchange rates, and general economic conditions remain key risks.
Investor Verification Checklist
- Verify the sustainability of the 8% sales volume increase across all segments, particularly in the recession-sensitive Polymers segment.
- Monitor the trend in operating cash flow, specifically the impact of rising inventory and receivables on liquidity.
- Review the status of environmental remediation projects (Maywood, Lightman) to ensure accrued liabilities ($16.8 million) remain adequate.
- Track the execution of planned capital expenditures ($65M-$75M) and the impact of rising raw material costs on future gross margins.
- Confirm the terms and pricing of the new $60 million revolving credit facility and the proposed $40 million long-term debt issuance.